Integral Health Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-550,000
Closed -$13.2M 100
2026
Q1
$13.2M Buy
550,000
+300,000
+120% +$7.33M 0.63% 41
2025
Q4
$5.66M Sell
250,000
-550,000
-69% -$12M 0.28% 69
2025
Q3
$16.1M Buy
800,000
+450,000
+129% +$7.54M 1.09% 27
2025
Q2
$5M Buy
+350,000
New +$4.09M 0.46% 56
2024
Q3
Sell
-450,000
Closed -$6.49M 75
2024
Q2
$6.49M Sell
450,000
-100,000
-18% -$1.6M 0.62% 48
2024
Q1
$8.95M Buy
550,000
+50,000
+10% +$782K 0.83% 48
2023
Q4
$7.45M Sell
500,000
-248,000
-33% -$2.81M 1.01% 43
2023
Q3
$8.41M Buy
748,000
+548,000
+274% +$6.36M 1.16% 36
2023
Q2
$2.01M Buy
+200,000
New +$1.86M 0.25% 71

Other funds holding ELAN

Integral Health Asset Management's ELAN Position: Q2 2026 in Review

Integral Health Asset Management sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 550,000 shares — an estimated $13.2M sold.

Integral Health Asset Management first reported a position in ELAN in Q2 2023 and held it in 9 quarters. The position peaked at $16.1M in Q3 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Integral Health Asset Management reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 550,000 Elanco Animal Health shares in Q2 2026, an estimated $13.2M.
  • Integral Health Asset Management first reported a position in Elanco Animal Health in Q2 2023 and held it in 9 quarters.
  • Integral Health Asset Management's Elanco Animal Health position peaked at $16.1M in Q3 2025.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.